Pan Ko, MD
Infectious Disease · Englewood Cliffs, NJNPI 1083851687
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,990 of the $15,617 with a category attached, or 64.0%. 27 manufacturers reported payments, led by AbbVie at 41.2% of the total. Reporting peaked in 2019 at $4,180 and has fallen 60.1% since, to $1,666 in 2025. Among infectious disease clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 482 payments — averaging $32.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$6K
- Gilead$3K
- Viiv Healthcare Company$1K
- Smith+Nephew$723
- Insmed, Inc.$618
- Organogenesis Inc.$548
- plus $3K from 21 others
What the payments were for
- Consulting fees$3002%
- Speaking & faculty fees$4,20027%
- Travel & lodging$8405%
- Food & beverage$9,99064%
- Education$2862%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 55 | $6,440 |
| Gilead | 181 | $2,884 |
| Viiv Healthcare Company | 93 | $1,143 |
| Smith+Nephew | 19 | $723 |
| Insmed, Inc. | 28 | $618 |
| Organogenesis Inc. | 5 | $548 |
| Merck | 27 | $406 |
| Celltrion Healthcare Co., Ltd | 1 | $300 |
| Johnson & Johnson(2 entities) | 11 | $292 |
| Integra Lifesciences Corporation | 2 | $275 |
| Sanofi-aventis U.S. LLC | 2 | $259 |
| Paratek Pharmaceuticals, Inc. | 17 | $233 |
| Amgen | 4 | $143 |
| Tactile Systems Technology Inc | 3 | $142 |
| Janssen Products, LP | 2 | $130 |
| Melinta Therapeutics, LLC | 8 | $130 |
| Urgo Medical North America, LLC | 1 | $126 |
| Abbott | 1 | $125 |
| Radius Health, Inc. | 1 | $122 |
| Boehringer Ingelheim | 1 | $121 |
| EMD Serono, Inc. | 7 | $119 |
| Intuity Medical Inc | 1 | $114 |
| Octapharma USA, Inc. | 3 | $72 |
| Napo Pharmaceuticals Inc | 3 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Invivyd Inc | 2 | $33 |
| Cardiovascular Systems Inc. | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DALVANCE$2,730
- AVYCAZ$2,331
- INTEGRA$825
- TEFLARO$325
- INTEGRA DERMAL REGENERATION TEMPLATE$275
- PRIMATRIX$275
- PURAPLY WOUND MATRIX$275
- COLLAGENASE SANTYL$273
- PuraPly$160
- Affinity$150
- Apligraf$150
- ACTICOAT 4" X 4"$148
- ALLEVYN HEEL 10.5CM X 13.5CM CTN 5$148
- Iodosorb Ointment 40g USA$148
- EMBLAVEO$143
- SOLIQUA 100/33$142
- Flexitouch Plus$129
- Nimbl$129
- VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP$126
- DRAWTEX HYDROCONDUCTIVE WOUND DRESSING WITH LEVAFIBER 4X4$126
How this compares
$15,617 in reported general payments places this provider in the 90th percentile of 334 infectious disease providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ArikayceAmikacin Liposomal/Neb.Accessr | 16 | $241,233 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 26 | $126,218 |
| DovatoDolutegravir Sodium/Lamivudine | 25 | $74,962 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 12 | $50,480 |
| JulucaDolutegravir/Rilpivirine | 12 | $48,530 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 11 | $48,448 |
| Isentress HdRaltegravir Potassium | 14 | $38,133 |
| CeftriaxoneCeftriaxone Sodium | 52 | $7,195 |
| Methenamine Hippurate | 53 | $5,292 |
| Vancomycin Hcl | 40 | $4,559 |
| Linezolid | 14 | $2,074 |
| Cephalexin | 36 | $1,395 |
| Doxycycline Hyclate | 69 | $1,358 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $596 |
| Fluconazole | 28 | $572 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Insmed, Inc.Arikayce | $618 | $241,23316 claims |
| Viiv Healthcare CompanyDovato, Triumeq, Juluca | $1,143 | $173,97349 claims |
| GileadBiktarvy | $2,884 | $126,21826 claims |
| Janssen Products, LPSymtuza | $130 | $48,44811 claims |
| MerckIsentress Hd | $406 | $38,13314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 334 infectious disease providers in New Jersey.
Other infectious disease in Englewood Cliffs
- Keith GottesdienerRahway$2.1M
- Jihad SlimNewark$2.1M
- Maria SzabelaNewark$474K
- Ronald NahassHillsborough$213K
- Christopher LucastiSomers Point$112K
- Spartaco BellomoJersey City$111K
- Jack BoghossianBayonne$97K
- Adriana GrigoriuJersey City$89K
- Sukrut DwivediOakhurst$75K
- Bindu BalaniHackensack$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.